Study to Evaluate the Effect of Nicotinamide Riboside on Immunity
Clinical trial NCT02812238 · COMPLETED
Trial details
- NCT number
- NCT02812238
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-23
- Primary completion
- 2018-08-28
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.